The sonohysterography catheters market will experience stable growth from 2025 until 2035 because of advancing uterine abnormality rates combined with greater use of minimally invasive gynecological diagnostics and expanding language about early fertility evaluation.
Specialized catheters in sonohysterography perform sterile fluid infusion into the uterine cavity to improve ultrasound imaging sound quality. Market analysts project a 5.3% annual growth rate between 2025 and 2035 which will increase the market from its current USD 14.8 million value to USD 24.8 million.
The diagnostic evaluation of fibroids along with polyps and uterine anomalies and endometrial thickness occurs through these catheters which serve women reviewing infertility or abnormal bleeding symptoms. Patients prefer sonohysterography as their primary diagnostic technique because of its ease of use combined with minimal complications and outpatient’s suitability.
The expansion of world-class ultrasound devices and active expansion of gynecological testing programs enhances worldwide market adoption mainly in reproductive healthcare facilities and ambulatory surgical centers.
Key Market Metrics
| Metric | Value |
|---|---|
| Industry Size (2025E) | USD 14.8 million |
| Industry Value (2035F) | USD 24.8 million |
| CAGR (2025 to 2035) | 5.3% |
The region led the market because of access to newer ultrasound technology, higher utilization of fertility services, and strong emphasis on early gynecological diagnosis procedures. Increasing use of sonohysterography catheters in women health centers and OB-GYN offices in the USA and Canada is also notable.
Europe appears to be growing steadily as many countries such as Germany, France, and the UK are increasing access to outpatient diagnostic procedures. The national guidelines that endorse minimally invasive uterine imaging have allowed for comparative sonohysterography use, especially in reproductive endocrinology and menopausal care.
A new high-growth region burgeons thanks to growing demand for fertility care, improved gynecological screening infrastructure, and women's health awareness. India's, Japan's, and China's expanding access to diagnostic imaging and specialist clinics are increasing demands for sonohysterography procedures.
Challenge
Procedure Sensitivity and Limited Standardization
Sonohysterography catheters have limited invasive application and lack standardization with respect to technique. This has made it difficult for many patients to experience the discomfort and infection risks associated with use by well-trained healthcare practitioners for general gynecology practice.
The lack of established protocols throughout clinical environments has adversely impacted diagnostic accuracy concerning the detection of polyps, fibroids, or intrauterine adhesions. Low-resource environments also have poor access to high-quality and sterile ultrasound equipment, thus further limiting application. These things lower procedural efficiency and the consistency of diagnosis in situations that are mostly outside specialized fertility and diagnostic imaging centers.
Rising Infertility Diagnosis and Minimally Invasive Imaging Demand
In spite of all the barriers from the procedures, the market for sonohysterography catheters grows at quite a pace because there's an incline towards as internal examination methods that are minimally invasive for assessing fertility as well as evaluation of uterine diseases.
A real-time visualization of the uterine cavity with saline infusion gives a much safer and less expensive alternative to hysteroscopy. Innovations in technology, such as balloon-tip catheters, smaller French, and better biocompatible materials, promote patient comfort and success of procedure.
The more infertility evaluations and outpatient gynecologic imaging increase, particularly in aging populations and urban clinics, the more the population both in developed and emerging healthcare markets is expected to take advantage of the opportunity from the reliable, easy-to-use sonohysterography catheters.
From 2020 to 2024, sonohysterography began to gain clinical popularity in fertility clinics and gynecology practices for the evaluation of cases involving abnormal uterine bleeding and submucosal lesions. Disposable and single-use catheters with integrated balloon tips were established as the norm in outpatient procedures.
From 2025 to 2035, the market is expected to respond with ergonomic, ultrasound-friendly catheters that offer antimicrobial coating as well as real-time pressure feedback systems. AI-assisted imaging interpretation will open increased market avenues along with the rising demand for office-based diagnostics. Computerized integration into EMRs and fertility platforms will strengthen patient management and procedural record keeping.
Market Shifts: Comparative Analysis (2020 to 2024 vs. 2025 to 2035)
| Market Factor | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Focused on sterility, single-use validation, and ultrasound safety. |
| Technological Advancements | Use of balloon-tip and open-end disposable catheters. |
| Sustainability Trends | High reliance on single-use plastics and manual disposal. |
| Market Competition | Led by women’s health product manufacturers and OB/GYN distributors. |
| Industry Adoption | Common in fertility clinics, outpatient OB/GYN settings, and hospitals. |
| Consumer Preferences | Focused on diagnostic accuracy and minimal discomfort. |
| Market Growth Drivers | Boosted by infertility evaluations and abnormal uterine bleeding diagnosis. |
| Market Factor | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Expansion into antimicrobial safety standards, device tracking, and integrated data compliance. |
| Technological Advancements | Growth in pressure-sensitive, ergonomic, and AI-guided sonohysterography tools. |
| Sustainability Trends | Shift toward biodegradable materials, recyclable packaging, and low-waste sterilization systems. |
| Market Competition | Entry of digital imaging firms and fertility-focused medtech innovators. |
| Industry Adoption | Expands to tele-imaging platforms, ambulatory surgical centers , and preventive screening programs. |
| Consumer Preferences | Shift to quick recovery, eco-safe disposables, and tech-integrated procedural experiences. |
| Market Growth Drivers | Accelerated by global fertility awareness, minimally invasive diagnostics, and women’s health investments. |
Sonohysterography catheters are experiencing steady growth in the United States owing to rising awareness regarding uterine health and the acceptance of minimally invasive diagnostic modalities across gynecology. Saline infusion sonography is being used in USA OB-GYN clinics and fertility centers for accurate, immediate assessment of the uterus under real-time conditions.
Improvements in technology such as the balloon-tip and dual-lumen designs are increasing comfort and clarity of diagnosis, especially in the outpatient and fertility-based care environments.
| Country | CAGR (2025 to 2035) |
|---|---|
| USA | 5.1% |
In the United Kingdom, NHS-guided initiatives for improving early detection of uterine abnormalities and streamlining fertility investigations support the market. Sonohysterography has now become a routine step prior to hysteroscopy or IVF, thereby increasing the demand for good quality, flexible catheters.
Soft-tipped catheter variants with designs to ensure self-retention while minimizing patient discomfort during the procedure are being adopted in clinics across the UK.
| Country | CAGR (2025 to 2035) |
|---|---|
| UK | 5.0% |
The European Union presents a steadily growing market for sonohysterography catheters, particularly in Germany, France, and the Netherlands where fertility preservation and preventive gynecologic screening are gaining prominence.
EU clinicians favour CE-marked, latex-free, and dual-lumen catheter systems that support enhanced imaging and are suitable for a broad range of uterine evaluations. Rising demand for early, non-invasive diagnostics is propelling broader market adoption across outpatient gynecology.
| Region | CAGR (2025 to 2035) |
|---|---|
| European Union | 5.3% |
The Japanese sonohysterography catheters market is somewhat gradually expanding along with increasing utilization in reproductive medicine and gynecologic oncology. Saline infusion sonography is already being included in the regular diagnostics of fertility assessment and endometrial evaluation by Japanese gynecologists.
Product design trends are favouring miniaturized patient-friendly catheters that offer precise placement and compatibility with high-resolution ultrasound systems being utilized in Japanese hospitals and fertility clinics.
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.2% |
Sonohysterography catheters market in South Korea is registering robust growth due to increasing fertility awareness, better access to gynecologic ultrasound, and growing acceptance for non-invasive diagnostics. Fertility centers and general hospitals have quickly embraced advanced catheter systems for precise evaluations of uterine factors that are affecting conception.
Wide acceptance exists for catheter brands either locally manufactured or imported that claim enhanced control during insertion, good saline flow, and reduced procedural time across women's health centers.
| Country | CAGR (2025 to 2035) |
|---|---|
| South Korea | 5.6% |
The sonohysterography catheters market is thriving to meet the demands for advanced diagnostic technologies in gynecology. Sonohysterography or saline infusion sonography uses sterilized fluid infusion into the uterine cavity via catheter prior to transvaginal ultrasound, thus providing access to detailed imaging of the uterine cavity.
Out of the three product types, double lumen catheters dominate the market due to their ability to efficiently fill and depressurize the cavity with sterile fluid by allowing an efflux of air. Hospitals, on the other hand, not only lead the end-user segment due to their fully developed imaging infrastructure and trained personnel, but also due to the high volumes of procedures being performed.
These two reverse and anterior segments enhance the diagnostic accuracy of intrauterine abnormalities including fibroid, polyp, adhesion, and structural anomalies, thus promoting the adoption of these procedures in routine screening and fertility workups.
| Product Type | Market Share (2025) |
|---|---|
| Double Lumen | 57.8% |
The double-lumen catheters are the leading products in the sonohysterography catheters market because of the diagnostic imaging capabilities they possess. With these catheters, clinicians are able to infuse saline and aspirate air simultaneously, thus preventing distortion of the image due to bubbles while allowing adequate uterine distension.
For complex diagnostic procedures, such as fertility studies as well as investigations for abnormal uterine bleedings, endometrial cavity visualization is paramount; hence, the doctors prefer using double-lumen catheters. More effective fluid management creates greater accuracy in the diagnosis and improved procedural efficiency.
Device manufacturers innovate in design double-lumen catheters with soft, kink-resistant tubing, malleable tips, and secure placement balloons. In creating innovations with benefits to minimize discomfort and procedural complications for patients and enhance clinician control, double-lumen catheters are becoming more and more important as these occur with increasingly implemented minimally invasive diagnostic instruments in gynecologic practice.
In the future, double lumen catheters will be a trusted and best option for high-resolution intrauterine imaging because of the recent developments in technology aiding this practice. Increased use of the double-lumen catheter can be seen in the bigger context of precision diagnostics as well as the more patient-centered care within women's health.
| End User Type | Market Share (2025) |
|---|---|
| Hospitals | 60.3% |
The end-user segment in the catheters market for sonohysterography is hospitals that provide complete gynecologic services and a high number of diagnostic procedures. Most hospitals are best equipped with the latest in ultrasound technology, are associated with pathology and fertility clinics on-site, making them the perfect infrastructure for saline infusion sonography.
Gynecologists in hospital settings often use sonohysterography catheters during abnormal bleeding, infertility, or recurrent pregnancy loss evaluations by uterine health. There would be the follow-up procedures immediately available at a hospital, such as hysteroscopy or biopsy, to ensure continuity of care.
Hospital healthcare administrators prefer using efficient, patient-friendly tool designs to maximize procedural outcome and improve patient satisfaction. This made the technique popularly linked with outpatient imaging and women's health departments.
Hospitals, being referral centers, are also known for more complex gynecologic conditions, which tend to be the other reason for increased acceptance of specialized catheters and diagnostic accessories. As women's health initiatives grow and hospitals become more accessible to non-invasive imaging services, so will the role of hospitals in the adoption of sonohysterography catheters continue to shape market trends globally.
The specialized global market for sonohysterography catheters serves the needs of women’s health diagnostics when administering saline infusion sonography (SIS) and contrast-enhanced hysterosonography for endometrial cavity assessment.
Before IVF procedures medical personnel use these catheters for diagnosing a variety of intrauterine conditions plus endometrial polyps along with fibroids and such anomalies as adhesions during endometrial examinations.
Ultrasound-guided sonohysterography provides patients with a lower invasive procedure compared to traditional hysteroscopy which also lowers their sense of discomfort. Market expansion occurs because of increased infertility rates and increased ultrasound use in gynecology practices and affordable uterine assessment needs.
Companies within this market emphasize competing through the development of flexible catheter tips along with optimal balloon performance and lumen design and ultrasound compatibility and sterility packaging solutions.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| CooperSurgical , Inc. | 28-32% |
| Cook Medical, Inc. | 18-22% |
| MedGyn Products, Inc. | 12-16% |
| Thomas Medical Inc. | 9-13% |
| Rocket Medical plc | 6-10% |
| Other Companies (combined) | 15-20% |
| Company Name | Key Offerings/Activities |
|---|---|
| CooperSurgical , Inc. | Offers the SofTrace ™ and ClearView ™ sonohysterography catheter lines with malleable shaft and adjustable balloon control for OB/GYN imaging in 2025. |
| Cook Medical, Inc. | Markets the Goldstein SonoBiopsy ™ Catheter and EchoTip ® uterine infusion catheters for saline or contrast infusion in infertility evaluations in 2024. |
| MedGyn Products, Inc. | Supplies flexible, single-use sonohysterography catheters with echogenic tips and integrated stopcocks for enhanced ultrasound visualization in 2025. |
| Thomas Medical Inc. | Developed balloon-in-tip and side-ported SIS catheters in sterile packs with color-coded hubs and patient comfort tubing for fertility clinics in 2024. |
| Rocket Medical plc | Provides sonohysterography and HSG catheters with latex-free design, dual-lumen configurations, and EU-standard packaging for public hospital systems in 2024. |
Key Company Insights
CooperSurgical, Inc.
CooperSurgical leads the market with a broad suite of diagnostic catheters for uterine imaging, including its versatile ClearView™ series. Known for flexible shafts, adjustable balloon inflation, and compatibility with transvaginal ultrasound, its catheters are widely used in pre-IVF workups.
Cook Medical, Inc.
Cook offers high-precision uterine infusion catheters such as the Goldstein SonoBiopsy™, which combines saline infusion with sampling capabilities. Its products are favored in minimally invasive gynecology for their procedural control and ultrasound clarity.
MedGyn Products, Inc.
MedGyn provides cost-effective, high-visibility SIS catheters for global OB/GYN clinics. With soft, echogenic tips and intuitive fluid management systems, its devices enable safe and accurate uterine evaluations in both urban and rural healthcare systems.
Thomas Medical Inc.
Thomas Medical is recognized for its ergonomic SIS catheters featuring balloon-in-tip designs that minimize cervical trauma and improve saline flow control. Its color-coded system aids in procedural efficiency in reproductive health centers.
Rocket Medical plc
Rocket Medical supplies SIS and HSG catheters across Europe and Asia, focusing on latex-free, dual-lumen products with smooth insertion and precise balloon inflation. Its regulatory-certified packaging supports standardized clinical deployment.
Other Key Players (15 to 20% Combined)
Numerous regional OB/GYN suppliers and sterile device manufacturers contribute to the sonohysterography catheters market through private-label production, fertility clinic supply partnerships, and diagnostic innovation:
The overall market size for the sonohysterography catheters market was USD 14.8 million in 2025.
The sonohysterography catheters market is expected to reach USD 24.8 million in 2035.
The increasing use of ultrasound in gynecological diagnostics, rising demand for minimally invasive procedures, and growing adoption of double lumen catheters in hospital-based procedures fuel the sonohysterography catheters market during the forecast period.
The top 5 countries driving the development of the sonohysterography catheters market are the USA, UK, European Union, Japan, and South Korea.
Double lumen catheters and hospital-based procedures lead market growth to command a significant share over the assessment period.
Explore Therapeutic Device Insights
Sonohysterography Catheters Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
